NUCLEAR TECHNIQUES, Volume. 48, Issue 6, 060006(2025)

Research and application progress of labeling chemistry of radioactive metal nuclides with chelating agents

Liya WEI, Jingfei XU, Jiang YU, Wenbin HOU, and Yiliang LI*
Author Affiliations
  • Institute of Radiation Medicine, Peking Union Medical College, Chinese Academy of Medical Sciences, Tianjin 300192, China
  • show less
    Figures & Tables(13)
    Schematic of the composition of radioactive drugs
    Diagram of radionuclide decay types and their corresponding applications in nuclear medicine
    Structural diagram of some selected chelating agents
    • Table 1. Properties and applications of selected radioactive metal nuclides[3,12]

      View table
      View in Article

      Table 1. Properties and applications of selected radioactive metal nuclides[3,12]

      放射性核素

      Radionuclide

      离子半径和配位数

      Ionic radius (pm) and Coordination number (CN)

      半衰期(t1/2

      Half time (t1/2) / h

      主要衰变模式和分支

      Main decay mode and branching

      衰变粒子的平均能量

      Average energy of decay particle / keV

      应用

      Application

      诊断性核素Diagnostic nuclide
      68Ga62 pm (CN=6)1.13β+ (89%)β+, 830; γ, 511PET
      111In92 pm (CN=8)67.2EC (100%)γ, 171, 245SPECT
      64Cu73 pm (CN=6)12.7β+ (19%)656PET
      44Sc87 pm (CN=8)4.04β+ (94%)632PET
      89Zr84 pm (CN=8)78.41β+ (23%)395.5PET
      203Pb119 pm (CN=6)51.87γ (81%)279.2SPECT
      治疗性核素Therapeutic nuclide
      177Lu98 pm (CN=8)159β- (100%)134β- therapy
      90Y102 pm (CN=8)64β- (100%)934β- therapy
      67Cu73 pm (CN=6)61.8β- (100%)561β- therapy
      225Ac112 pm (CN=6)238α (100%)5 800~8 400α therapy
      212Pb129 pm (CN=8)10.64β- (64%), α (36%)β-, 570; α, 6 050α therapy
    • Table 2. Labeling parameters and applications of chelating agents for 68Ga

      View table
      View in Article

      Table 2. Labeling parameters and applications of chelating agents for 68Ga

      放射性核素

      Radionuclide

      螯合剂

      Chelator

      标记条件

      Labeling conditions

      条件依赖性参数pM

      生物共轭物

      Bioconjugate

      靶点

      Target

      参考文献

      Reference

      68GaDOTApH 5.5, 100 ℃, 10 min18.5Tyr3-octreotateSSTR[8,18]
      NOTApH 3, RT, 10 min26.4Cys40-Leu14-Exendin 4GLP-1R[19,21]
      HBEDpH 4.5, 85 ℃, 3 min30.8PSMA-11PSMA[22]
      H2dedpapH 4.5, RT, 10 min27.4c(RGDyK)Integrin αvβ3[26]
    • Table 3. Labeling parameters and applications of chelating agents for 177Lu

      View table
      View in Article

      Table 3. Labeling parameters and applications of chelating agents for 177Lu

      放射性核素

      Radionuclide

      螯合剂

      Chelator

      标记条件

      Labeling conditions

      条件依赖性参数

      pM

      生物共轭物

      Bioconjugate

      靶点

      Target

      参考文献

      Reference

      177LuDOTApH 5.5, 100 °C, 10 min20.8Tyr3-octreotateSSTR[8]
      H4octapapH 5.5, RT, 15 min19.8TrastuzumabHER2[36]
      H4pypapH 7, RT, 15 min22.6PSMA-617PSMA[36]
      bispidine-L26pH 4.8, RT, 5 min10.8PEG2-TATESSTR[40]
    • Table 4. Labeling parameters and applications of chelating agents for 90Y

      View table
      View in Article

      Table 4. Labeling parameters and applications of chelating agents for 90Y

      放射性核素

      Radionuclide

      螯合剂

      Chelator

      标记条件

      Labeling conditions

      条件依赖性参数pM

      生物共轭物

      Bioconjugate

      靶点

      Target

      参考文献

      Reference

      90YDOTApH 5.5, 100 ℃, 10 min19.8TATESSTR[43]
      CHX-A"-DTPApH 5.5, RT, 30 min19TrastuzumabHER2[44]
      H4octapapH 5.5, RT, 15 min18.1TrastuzumabHER2[42]
    • Table 5. Labeling parameters and applications of chelating agents for 111In

      View table
      View in Article

      Table 5. Labeling parameters and applications of chelating agents for 111In

      放射性核素

      Radionuclide

      螯合剂

      Chelator

      标记条件

      Labeling conditions

      条件依赖性参数pM

      生物共轭物

      Bioconjugate

      靶点

      Target

      参考文献

      Reference

      111InDOTApH 5.5, 80 ℃, 20 min18.8Phe1-octreotideSSTR[47]
      CHX-A"-DTPApH 5.5, 40℃, 40 min24.4~25.7Phe1-octreotideSSTR[47]
      p-SCN-Bn-H6phospapH 5.5, RT, 30 min38.64TrastuzumabHER2[48]
      H4pypapH 6, RT, 10 min30.5PSMA-617PSMA[38,52]
      H4picoopapH 5.5-7.0, RT, 10 min31.2Pip-Nle-CycMSHhexMC1R[48]
    • Table 6. Labeling parameters and applications of chelating agents for 64/67Cu

      View table
      View in Article

      Table 6. Labeling parameters and applications of chelating agents for 64/67Cu

      放射性核素

      Radionuclide

      螯合剂

      Chelator

      标记条件

      Labeling conditions

      条件依赖性参数pM

      生物共轭物

      Bioconjugate

      靶点

      Target

      参考文献

      Reference

      64/67CuDOTApH 5-6, 90 °C, 30 min17.6DipepPSMA[57]
      NOTApH 4.5, RT, 10 min18.2DipepPSMA[57]
      p-SCN-PhPr-NE3TApH 5-7, RT, 10 minNDPEG4-LLP2AVLA-4[61]
      TE2ApH 8, RT, 10 minNDTrastuzumabHER2[62]
    • Table 7. Labeling parameters and applications of chelating agents for 44Sc

      View table
      View in Article

      Table 7. Labeling parameters and applications of chelating agents for 44Sc

      放射性核素

      Radionuclide

      螯合剂

      Chelator

      标记条件

      Labeling conditions

      条件依赖性参数pM

      生物共轭物

      Bioconjugate

      靶点

      Target

      参考文献

      Reference

      44ScDOTApH 2~5, 95 °C,10~30 min26.5Tyr3-octreotateSSTR[67-68]
      AAZTApH 2~7, 25 ℃, 30 min24.72c(RGDyK)integrin αvβ3[66]
    • Table 8. Labeling parameters and applications of chelating agents for 225Ac

      View table
      View in Article

      Table 8. Labeling parameters and applications of chelating agents for 225Ac

      放射性核素

      Radionuclide

      螯合剂

      Chelator

      标记条件

      Labeling conditions

      条件依赖性参数pM

      生物共轭物

      Bioconjugate

      靶点

      Target

      参考文献

      Reference

      225AcDOTApH 9, 37~60 ℃, 30~120 min19.2TrastuzumabHER2[67,69]
      H2macropapH 6, RT, 5 minNDCodrituzumabGlypican-3[70]
      H2BZmacropa-NCSpH 6, RT, 5 minNDCodrituzumabGlypican-3[70]
      H4py4papH 7, RT, 30 minNDTrastuzumabHER2[71]
      H4picoopapH 5.5~7.0, RT, 10 minNDPip-Nle-CycMSHhexMC1R[52]
    • Table 9. Labeling parameters and applications of chelating agents for 89Zr

      View table
      View in Article

      Table 9. Labeling parameters and applications of chelating agents for 89Zr

      放射性核素

      Radionuclide

      螯合剂

      Chelator

      标记条件

      Labeling conditions

      条件依赖性参数pM

      生物共轭物

      Bioconjugate

      靶点

      Target

      参考文献

      Reference

      89ZrDOTAGApH 6.9~7.2, 90 ℃, 45 minNDTrastuzumabHER2[82]
      DFOpH 7~7.3, 25 ℃, 60 minNDTrastuzumabHER2[73]
      DFO*pH 7.4, RT, 15~30 minNDTrastuzumabHER2[74]
      DFOcyclo*pH 7.4, RT, 15~30 minNDTrastuzumabHER2[75]
      HOPOpH 7, RT, 10 minNDTrastuzumabHER2[78]
      FSCpH 6.8~7.2, 25 °C, 90 minNDRDGHER2[79]
    • Table 10. Labeling parameters and applications of chelating agents for 203/212Pb

      View table
      View in Article

      Table 10. Labeling parameters and applications of chelating agents for 203/212Pb

      放射性核素

      Radionuclide

      螯合剂

      Chelator

      标记条件

      Labeling conditions

      条件依赖性参数pM

      生物共轭物

      Bioconjugate

      靶点

      Target

      参考文献

      Reference

      203/212PbDOTApH 5.5, 75 ℃, 30~60 min18.7Phe1 -Tyr3 -octreotideSSTR[87]
      DOTAMApH 5.4, 85°C, 30 minNDPhe1 -Tyr3 -octreotideSSTR[87]
      TCMCpH 4.5, 37°C, 60 minNDTrastuzumabHER2[85]
    Tools

    Get Citation

    Copy Citation Text

    Liya WEI, Jingfei XU, Jiang YU, Wenbin HOU, Yiliang LI. Research and application progress of labeling chemistry of radioactive metal nuclides with chelating agents[J]. NUCLEAR TECHNIQUES, 2025, 48(6): 060006

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Save article for my favorites
    Paper Information

    Category: Special Topics of Academic Papers at The 27th Annual Meeting of the China Association for Science and Technology

    Received: May. 29, 2025

    Accepted: --

    Published Online: Jul. 25, 2025

    The Author Email: Yiliang LI (李祎亮)

    DOI:10.11889/j.0253-3219.2025.hjs.48.250225

    Topics